Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-413.83%
operating margin TTM
-319.98%
revenue TTM
10.00 Million
revenue per share TTM
0.13$
valuation ratios | |
|---|---|
| pe ratio | -2.17 |
| peg ratio | -0.22 |
| price to book ratio | -1.99 |
| price to sales ratio | 9.11 |
| enterprise value multiple | -3.74 |
| price fair value | -1.99 |
profitability ratios | |
|---|---|
| gross profit margin | 99.38% |
| operating profit margin | -319.98% |
| pretax profit margin | -413.83% |
| net profit margin | -413.83% |
| return on assets | -109.31% |
| return on equity | 126.5% |
| return on capital employed | -104.58% |
liquidity ratio | |
|---|---|
| current ratio | 4.49 |
| quick ratio | 4.49 |
| cash ratio | 2.48 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 37.34 |
| days of payables outstanding | 17,953.44 |
| cash conversion cycle | -17,916.10 |
| receivables turnover | 9.78 |
| payables turnover | 0.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | -0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.02 |
| interest coverage | -2.60 |
| cash flow to debt ratio | -24.14 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.26 |
| cash per share | 0.32 |
| operating cash flow per share | -0.25 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -24.14 |
| short term coverage ratios | -50.80 |
| capital expenditure coverage ratio | -29.02 |
Frequently Asked Questions
When was the last time Clearside Biomedical, Inc. (NASDAQ:CLSD) reported earnings?
Clearside Biomedical, Inc. (CLSD) published its most recent earnings results on 12-11-2024.
What is Clearside Biomedical, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Clearside Biomedical, Inc. (NASDAQ:CLSD)'s trailing twelve months ROE is 126.5%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Clearside Biomedical, Inc. (CLSD) currently has a ROA of -109.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CLSD's net profit margin stand at?
CLSD reported a profit margin of -413.83% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CLSD's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.49 in the most recent quarter. The quick ratio stood at 4.49, with a Debt/Eq ratio of -0.02.